Oral Corticosteroids in Asthma Care – Corticosteroid Stewardship Statement

It is time to protect patients with asthma from potential overexposure to oral corticosteroids (OCS) – and to recognize OCS overuse for what it often is: a treatment plan failure.

OCS carry serious health risks. Innovative treatment options target certain types of severe or difficult-to-control asthma in ways never-before possible, reducing the need for OCS. Today, OCS use has become a signal that a patient may need an updated treatment plan, or support with adherence concerns. While OCS can be an important tool in managing asthma in certain cases, use should always be carefully monitored by a qualified asthma specialist, or a primary care provider with asthma expertise. NOTE: OCS should not be confused with ICS (inhaled corticosteroids), which have fewer risks.


Read more about this collaborative effort to curb OCS overexposure at: https://www.allergyasthmanetwork.org/education/severe-asthma/oral-corticosteroids-asthma-care/ 

Share this Post